Delivery Order SPE2DR25D2001-SPE2DR26FBGT7
Award Date 2/5/26
Potential Completion Date 2/6/26
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $24,161.48 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for RINVOQ ER 30 mg tablets (30-count bottles).</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is February 6, 2026. Pricing is firm fixed price with no set-aside.</p>
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for RINVOQ ER 45 mg tablets (28-tablet unit of use) with a ceiling value of $7,483.54. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026, enabling supply of pharmaceutical products and medical supplies to military healthcare...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for RINVOQ ER 30 mg tablets with a ceiling value of $25,151.53. The delivery order is issued under the DLA Troop Support Medical IDC, a comprehensive global pharmaceutical support vehicle valued up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is February 6, 2026. The order is firm fixed price with no set-aside.
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $11,243.34 for RINVOQ ER 15 MG tablets (30-count unit dose). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is Conshohocken, PA. The ultimate...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $6,836.70 for RINVOQ ER 30 mg tablets (30-count). Place of performance is Conshohocken, PA. Ultimate completion date is February 6, 2026. The order was issued under firm fixed-price terms with no set-aside. Amerisourcebergen Drug Corp operates under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December...
- <p>The Defense Logistics Agency issued a $22,589.63 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for supply of RINVOQ ER 45 MG tablets (28-count units).</p> <p>Place of performance is Conshohocken, PA. The order ceiling value is $22,589.63 with an ultimate completion date of February 6, 2026. Pricing is firm fixed price, and no set-aside was used.</p>
- The Defense Logistics Agency awarded a delivery order valued at $28,056.45 to AmerisourceBergen Drug Corp for RINVOQ ER 45 MG tablets (28-count unit of use packaging) on January 22, 2026, with an ultimate completion date of January 23, 2026. This is a firm fixed-price delivery order with no set-aside designation, issued under a fully competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET in the amount of $6,467.69. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $11,779.01 on November 18, 2025, for RINVOQ ER 15 mg tablets (30-count packages). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 19, 2025, and performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 4, 2026, with a ceiling value of $19,689.24 for supply of RINVOQ ER 15 MG tablets, 30-count units, with an ultimate completion date of February 5, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price and carries no set-aside. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support...